Myocarditis or ‘hot phase’ of arrhythmogenic cardiomyopathy? A case series
European Heart Journal - Case Reports · 01.10.2025 · 9 (10)
DOI: 10.1093/ehjcr/ytaf460 ↗Kurz gefasst
Fallbericht in der Zeitschrift European Heart Journal - Case Reports, online erschienen am 18.09.2025. Verfasst von André Ferreira und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Hospital de Santa Marta, Unidade Local de Saúde de São José, R. de Santa Marta 50, 1169-024 Lisbon, Portugal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Arrhythmogenic cardiomyopathy (ACM) is a genetic condition characterized by fibrofatty replacement of myocardial tissue, leading to arrhythmias and structural heart changes. Recent studies have identified an acute inflammatory phase, or ‘hot phase’, within the progression of ACM that presents with clinical features similar to myocarditis. This phase complicates the differentiation between ACM and myocarditis, posing a diagnostic challenge. Case summary We present two cases of young male patients, both with mutations in the DSP and LMNA genes, who initially presented with symptoms of myocardial inflammation. Patient 1, a 23-year-old male, presented with pleuritic chest pain, elevated troponin, and imaging findings suggesting myocarditis. Cardiac magnetic resonance (CMR) revealed extensive subepicardial late gadolinium enhancement (LGE) in a non-ischaemic pattern. Genetic testing confirmed a likely pathogenic (LP) LMNA mutation. Patient 2, a 26-year-old male with family history of sudden cardiac death, presented similarly with chest pain and elevated biomarkers. His CMR showed intramural LGE, and genetic testing identified a LP DSP mutation. He underwent implantation of a subcutaneous defibrillator (ICD) due to arrhythmic risk.
Discussion
This case series underscores the importance of recognizing the ‘hot phase’ of ACM, which can clinically mimic myocarditis. Cardiac magnetic resonance is crucial for differentiating these entities, while genetic testing confirms the diagnosis, offering prognostic information. Mutations in the LMNA and DSP genes, particularly associated with inflammation in ACM, require consideration of arrhythmia prevention strategies, such as ICD implantation. Multidisciplinary management and advanced imaging play essential roles in the care of these patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Hospital de Santa Marta, Unidade Local de Saúde de São José, R. de Santa Marta 50, 1169-024 Lisbon, Portugal.
ORCID-Profile: André Ferreira, Sílvia Aguiar Rosa
Zitieren
APA
Ferreira, A., Teixeira, R., Brás, P., Viegas, J., Almeida, I., Antunes, D., Ferreira, R. C., & Rosa, S. A. (2025). Myocarditis or ‘hot phase’ of arrhythmogenic cardiomyopathy? A case series. European Heart Journal - Case Reports, 9(10). https://doi.org/10.1093/ehjcr/ytaf460
Vancouver
Ferreira A, Teixeira R, Brás P, Viegas J, Almeida I, Antunes D, et al. Myocarditis or ‘hot phase’ of arrhythmogenic cardiomyopathy? A case series. European Heart Journal - Case Reports. 2025;9(10). doi:10.1093/ehjcr/ytaf460
BibTeX
@article{Ferreira2025,
author = {Ferreira, André and Teixeira, Rita and Brás, Pedro and Viegas, José and Almeida, Inês and Antunes, Diana and Ferreira, Rui Cruz and Rosa, Sílvia Aguiar},
title = {Myocarditis or ‘hot phase’ of arrhythmogenic cardiomyopathy? A case series},
journal = {European Heart Journal - Case Reports},
year = {2025},
volume = {9},
number = {10},
doi = {10.1093/ehjcr/ytaf460}
}
EUVIMED